U Wallin

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
    Helgi Birgisson
    Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden
    BMC Cancer 11:438. 2011
  2. ncbi Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?
    Ulrik Wallin
    Department of Surgery, Akademiska sjukhuset, 75185 Uppsala, Sweden
    Int J Colorectal Dis 25:1071-8. 2010
  3. ncbi Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
    U Wallin
    Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, 2800 Medical Building, 2800 Chicago Avenue South, Suite 300, Minneapolis, MN, USA
    Br J Cancer 104:1619-27. 2011

Detail Information

Publications3

  1. ncbi Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
    Helgi Birgisson
    Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden
    BMC Cancer 11:438. 2011
    ..The aim of this study was to compare different survival endpoints in patients with primary colorectal cancer (CRC) and to understand the effect of second primary other cancer on disease-free survival (DFS) calculations...
  2. ncbi Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?
    Ulrik Wallin
    Department of Surgery, Akademiska sjukhuset, 75185 Uppsala, Sweden
    Int J Colorectal Dis 25:1071-8. 2010
    ..The objective was to evaluate a new method for DNA sampling from the rectal mucosa for the detection of colorectal cancer or any clinically significant pathology in the colon and rectum...
  3. ncbi Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
    U Wallin
    Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, 2800 Medical Building, 2800 Chicago Avenue South, Suite 300, Minneapolis, MN, USA
    Br J Cancer 104:1619-27. 2011
    ..The aim of this study was to assess the prognostic value of GDF15 in patients with colorectal cancer (CRC)...